Target intelligence / Profile preview

Hemagglutinin protein of Influenza B virus Yamagata lineage (HA (Yamagata lineage))

Target
HA (Yamagata lineage)
Molecular classification
Viral protein, Glycoprotein, Fusion protein, Class I viral fusion protein
01

Overview

The hemagglutinin (HA) protein of the Influenza B virus Yamagata lineage is a major surface glycoprotein essential for viral entry into host cells. It mediates attachment to sialic acid receptors and subsequent membrane fusion. As a key immunogen, it is a crucial component of influenza vaccines, particularly quadrivalent formulations targeting both Yamagata and Victoria lineages. Antigenic variations within HA necessitate continuous surveillance and vaccine updates.

Other names
Influenza B Hemagglutinin (Yamagata)B/Yamagata HAHA protein (Yamagata lineage)
02

Mechanism of action

Binding to sialic acid receptors on host cells, triggering receptor-mediated endocytosis, followed by pH-dependent conformational change and membrane fusion. Vaccines elicit neutralizing antibodies that block HA's function.

03

Biological functions

Viral attachmentMembrane fusionReceptor binding (sialic acid)Immune recognition
04

Disease associations

InfectionInfluenza B virus infection
05

Safety considerations

Antigenic drift leading to vaccine mismatchEgg-adapted vaccine strain changes
06

Interacting drugs

NA (Hemagglutinin is the target of neutralizing antibodies elicited by vaccines)

2 more in the full profile.

Beyond the preview

Go deeper on Hemagglutinin protein of Influenza B virus Yamagata lineage (HA (Yamagata lineage)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein of Influenza B virus Yamagata lineage (HA (Yamagata lineage)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call